Platinum-induced hearing loss after treatment for childhood cancer.

Abstract

BACKGROUND Platinum-based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity. There is a wide variation in the reported prevalence of platinum-induced ototoxicity and… (More)
DOI: 10.1002/14651858.CD010181.pub2

17 Figures and Tables

Topics

  • Presentations referencing similar topics